Association between dyslipidemia and breast cancer risk: a retrospective case-control study stratified by menopausal status. [PDF]
Xu B, Ruan W, Yang Y.
europepmc +1 more source
Early capecitabine metronomic chemotherapy improves patient prognosis and safety in early-stage triple-negative breast cancer. [PDF]
Sun Y, Shang J, Duan K, Song Y, Yang Z.
europepmc +1 more source
Clinical Prognostic Value of C-Reactive Protein-Albumin-Lymphocyte Index (CALLY) in Patients with Stage III Breast Cancer. [PDF]
Zhu M +8 more
europepmc +1 more source
Machine learning integrating MRI and clinical features predicts early recurrence of hepatocellular carcinoma after resection. [PDF]
Feng L +7 more
europepmc +1 more source
Premenopausal Patients With Clinically Aggressive Metastatic Breast Cancer Successfully Treated With a First-Line Palbociclib-Containing Regimen: Two Cases and Literature Review. [PDF]
Fu PA, Hsu YC, Hsu HP, Lin TC, Chung WP.
europepmc +1 more source
Investigating radiotherapy's impact on intestinal perforation risk in gastrointestinal tumor patients treated with bevacizumab. [PDF]
He WM, Li WS.
europepmc +1 more source
Predicting the axillary lymph node tumor burden in breast cancer patients using ultrasonic radiomics nomogram model. [PDF]
Tang P +5 more
europepmc +1 more source
Development and validation of nomograms of outcomes for first-line platinum-based chemotherapy for metastatic triple-negative breast cancer: patient-level analysis of five prospective clinical trials in China. [PDF]
Gong C +10 more
europepmc +1 more source
Comment on 'the impact of body mass index on the efficacy of CDK4/6 inhibitors in patients with metastatic breast cancer'. [PDF]
Chen X, Gu S, Ding S.
europepmc +1 more source
Clinical efficacy of CT-guided iodine-125 seed brachytherapy in unresectable locoregionally recurrent breast cancer. [PDF]
Ji L, Zhang W, Hao S, Wang Z, Zhang G.
europepmc +1 more source

